20,00,000 free email id. free email database download. free email marketing Online

Maria Sharapova’s Drug Scandal video

Maria Sharapova's tennis career has demanded attention. She burst onto the scene in 2004, blasting Serena Williams off Wimbledon's Centre Court with searing groundstrokes and a grunt that sounds like a peacock in distress. The beauty of Sharapova's game, when it's on, is that there's no need for surgical precision. When she's at her best, her tennis is complete, eye-popping obliteration. The 6-foot-2 Siberian quickly assumed the role of tennis's glamour girl, and won the US Open two years later, in 2006. Two after that, in 2008, she once again played indomitable tennis and cruised to the Australian Open title. In 2012 and again in 2014, Sharapova conquered her worst surface — red clay — and took home trophies at the French Open.



Sharapova's tennis is now a topic of discussion once again. But this time, it's for a history-making act she wants no part of. Sharapova is the first premier tennis star in history to fail a doping test, and has admitted to using the banned endurance-enhancing drug known as 

meldonium.  What Maria Sharapova admitted On Monday, March 7, Sharapova admitted that she had failed a doping test, because she had been using a substance called meldonium, which is banned by the World Anti-Doping Agency (WADA), for most of her pro career. But she says her failed test was due to the fact that meldonium was only recently banned and she failed to recognize the updated list. "I had been legally taking the medicine for the past 10 years, but on January 1 the rules had changed, and meldonium became a prohibited substance, which I had not known," she told reporters at a press conference in Los Angeles.

Many pro and Olympic-level athletes have a team of people who support them — lawyers, handlers, assistants, coaches, managers — to ensure that oversights like this don't happen. To give Sharapova the benefit of the doubt, perhaps she keeps her team small